Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled, Optimized Titration Study of ABX-1431 in Adult Patients With Peripheral Neuropathic Pain

NCT03447756 is registered in ClinicalTrials.gov with Abide Therapeutics as lead sponsor.

NCT NCT03447756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03447756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled, Optimized Titration Study of ABX-1431 in Adult Patients With Peripheral Neuropathic Pain
Lead sponsor
Abide Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
October 2, 2017
Completion date
May 7, 2019
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic peripheral neuropathy, post herpetic neuralgia, post-traumatic neuralgia, small fiber neuropathy